loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

AVIENCE BIOMEDICALS IPO

UPCOMING

IPO Details

18th Jun 2026
22th Jun 2026
600
₹ 235,200
₹ 196-208
₹ 30 Crore

Issue timeline

  • 18-22 Jun 2026
  • 23-Jun-2026
  • 24-Jun-2026
  • 24-Jun-2026
  • 25-Jun-2026

About Company

Avience Biomedicals was incorporated on December 23, 2019. The company is engaged in the manufacturing of in-vitro diagnostic (IVD) products and medical devices from its facility in Noida, Uttar Pradesh. Its products support the detection of diseases, infections, and medical conditions through laboratory, healthcare, and home-based diagnostic testing applications
-
Name Designation
Dharam Deo Choudhary Chairman & Managing Director
Ram Nagina Choudhary Whole Time Director
Deepa Choudhary Director
Janardan Pal Director
Om Prakash Pal Independent Director
Pankaj Sharma Independent Director

Objectives

Part finances the capital expenditure towards setting up of a new manufacturing unit Gautam Buddha Nagar, Uttar Pradesh
Funding the working capital requirement of the company
To meet out the general corporate purposes

Strengths & Risks

Strengths (3)

The company offers a comprehensive portfolio of IVD rapid diagnostic tests and medical devices, including solutions for infectious disease detection, haematology, and biochemistry analysis. It also strengthens its product range through its association as a channel partner for Mindray, providing advanced diagnostic and laboratory equipment to healthcare providers

Risks (3)

The company relies on third-party logistics and transportation services for the timely movement of raw materials and finished products. Any disruption caused by transportation delays, accidents, natural disasters, or external factors could increase costs, affect supply chain efficiency, and adversely impact operations and customer deliveries

Financials

Frequently Asked Questions

Who are the promoters of Avience Biomedicals Ltd.?

The promoters of the company are Dharam Deo Choudhary, Ram Nagina Choudhary, Deepa Choudhary and Janardan Pal.

The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

The price band of the IPO is Rs 196.0 - 208.0.

The IPO application opens on Jun 18, 2026 and closes on Jun 22, 2026.

The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.